We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA Questions FDA’s Use of ICH Guidance In Draft Stability Testing Requirements
GPhA Questions FDA’s Use of ICH Guidance In Draft Stability Testing Requirements
January 15, 2013
The Generic Pharmaceutical Association (GPhA) is questioning the FDA’s use of an International Conference on Harmonisation (ICH) guideline to specify ANDA testing requirements when it was originally intended for new drug substances and products.